Your HER2 Positive Breast Cancer Specialists
HER2 positive breast cancer is an aggressive disease that represents about 25 percent of breast cancer cases. If you have been diagnosed with HER2-positive breast cancer, the experience and skill of the breast cancer specialists you choose will play a key role in your outcome, recovery and quality of life throughout your treatment process. For this reason and many others, individuals from throughout the country visit Moffitt Cancer Center’s HER2 Multidisciplinary Breast Clinic for highly specialized HER2 positive breast cancer treatment and supportive care.
A collaborative approach to HER2 positive breast cancer treatment
The HER2 positive breast cancer specialists at Moffitt excel in various medical disciplines and work hand-in-hand to develop individualized and well-rounded treatment plans for our patients. In one location, HER2 positive breast cancer patients benefit from the combined expertise of:
- Medical oncologists
- Radiation oncologists
- Fellowship-trained cancer surgeons
- Fertility preservation specialists
- Radiologists
- Pathologists
- Reconstructive surgeons
- Other specially trained professionals
Additionally, Moffitt is a high-volume cancer center, which means our breast cancer specialists see more complex forms of HER2 positive breast cancer than many other oncologists. The outstanding experience of our specialists, combined with our collaborative approach to treatment and clinical trials, translates directly into more positive outcomes and better quality of life for our patients.
Compassionate supportive care professionals
Breast cancer affects patients on more than a cellular level – it can be an overwhelming diagnosis that significantly impacts many aspects of an individual’s life. That’s why Moffitt’s team includes supportive care professionals who work with our breast cancer specialists in the same location that we provide clinical treatment, ensuring that our patients have all the guidance and tools they need to navigate the unique challenges of living with breast cancer. Our team of supportive care professionals includes:
- Social workers
- Counselors
- Dietitians
- Pain management specialists
- Massage therapists, yoga instructors, acupuncturists and other integrative medicine professionals
If you would like to consult a HER2 positive breast cancer specialist at Moffitt, submit a new patient registration form online or call 1-888-663-3488. A referral is not required to visit Moffitt.
-
Breast Oncology Program LeadershipDepartment Chair, Breast OncologyProgram Lead, Breast Oncology
Program
Breast Oncology
Title
Chair, Department of Breast Oncology
Specialty
Surgery
4.8 (219)Program
Breast Oncology
Title
Vice Chair, Department of Breast Oncology
Specialty
Medical Oncology
4.8 (150)
-
HER2 Positive Breast Cancer Surgeons
Meet the surgeons who specialize in the treatment of HER2 positive breast cancer.
Department Chair, Breast OncologyProgram Lead, Breast OncologyProgram
Breast Oncology
Title
Chair, Department of Breast Oncology
Specialty
Surgery
4.8 (219)Program
Breast Oncology
Title
Interim Program Leader, Reconstructive Oncology
Specialty
Surgery
4.9 (243)
-
HER2 Positive Breast Cancer Medical Oncologists
Meet the medical oncologists who specialize in the treatment of HER2 positive breast cancer.
Program Lead, Senior Adult OncologyProgram
Senior Adult Oncology
Title
Program Leader, Senior Adult Oncology Program
Specialty
Medical Oncology
4.9 (222)Program
Breast Oncology
Title
Vice Chair, Department of Breast Oncology
Specialty
Medical Oncology
4.8 (150)Program
Breast Oncology
Title
Medical Director of the Clinical Trials Office
Specialty
Medical Oncology
4.8 (89)
-
HER2 Positive Breast Cancer Plastic Surgeons
Meet the plastic surgeons who specialize in the treatment of HER2 positive breast cancer.
.
-
HER2 Positive Breast Cancer Radiation Oncologists
Meet the radiation oncologists who specialize in the treatment of HER2 positive breast cancer.
-
HER2 Positive Breast Cancer Radiologists
Meet the expert team of radiologists who specialize in finding and treating HER2 positive breast cancer.